the results of this trial extend our previous observations of long-term spontaneous changes in arrhythmia frequency to patients with symptomatic , potentially lethal ventricular arrhythmia and support the recommendation for periodic reassessment of baseline arrhythmia frequency to determine the continued need for antiarrhythmic therapy .
C0085612
ventricular arrhythmia
C0003811
arrhythmia